Literature DB >> 19748567

Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat.

Juan Hidalgo1, Sergi Florit, Mercedes Giralt, Beatriz Ferrer, Charlotte Keller, Henriette Pilegaard.   

Abstract

Interleukin-6 (IL-6) is a major cytokine involved in both normal physiological brain functions and underlying significant neuropathology. IL-6 has been suggested to play a role in the control of body weight but the results are somewhat controversial. In this study we have challenged transgenic mice with astrocyte-targeted IL-6 expression (GFAP-IL6 mice) with a high-fat diet (55% kcal from fat) versus a control diet (10%). The results demonstrate that the GFAP-IL6 mice are resistant to high-fat diet-induced increases in body weight and body fat, apparently without altering food intake and with no evidences of increased sympathetic tone. The high-fat diet-induced impaired responses to an insulin tolerance test (ITT), and to an oral glucose tolerance test (OGTT) in both genotypes. The GFAP-IL6 mice did not differ from littermate wild-type (WT) mice in ITT, but they were more glucose intolerant following the high-fat diet feeding. In summary, the present results demonstrate that brain-specific IL-6 controls body weight which may be a significant factor in physiological conditions and/or in diseases causing neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748567     DOI: 10.1016/j.bbi.2009.09.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  18 in total

Review 1.  Metabolic control and sex: A focus on inflammatory-linked mediators.

Authors:  Darren C Henstridge; Julie Abildgaard; Birgitte Lindegaard; Mark A Febbraio
Journal:  Br J Pharmacol       Date:  2019-04-21       Impact factor: 8.739

2.  Physical Activity, Obesity and Weight Loss Maintenance.

Authors:  Claus Brandt; Bente Klarlund Pedersen
Journal:  Handb Exp Pharmacol       Date:  2022

3.  Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function.

Authors:  Martin Valdearcos; Megan M Robblee; Daniel I Benjamin; Daniel K Nomura; Allison W Xu; Suneil K Koliwad
Journal:  Cell Rep       Date:  2014-12-11       Impact factor: 9.423

Review 4.  Physical activity and muscle-brain crosstalk.

Authors:  Bente Klarlund Pedersen
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

5.  Interleukin 6 deficiency modulates the hypothalamic expression of energy balance regulating peptides during pregnancy in mice.

Authors:  Patricia Pazos; Luis Lima; Felipe F Casanueva; Carlos Diéguez; María C García
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 6.  Hypothalamic inflammation: marker or mechanism of obesity pathogenesis?

Authors:  Joshua P Thaler; Stephan J Guyenet; Mauricio D Dorfman; Brent E Wisse; Michael W Schwartz
Journal:  Diabetes       Date:  2013-08       Impact factor: 9.461

7.  Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue.

Authors:  Jakob G Knudsen; Maria Murholm; Andrew L Carey; Rasmus S Biensø; Astrid L Basse; Tamara L Allen; Juan Hidalgo; Bronwyn A Kingwell; Mark A Febbraio; Jacob B Hansen; Henriette Pilegaard
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  Role of muscle IL-6 in gender-specific metabolism in mice.

Authors:  Amalia Molinero; Antonio Fernandez-Perez; Aina Mogas; Mercedes Giralt; Gemma Comes; Olaya Fernandez-Gayol; Mario Vallejo; Juan Hidalgo
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

9.  Energy Balance Regulating Neuropeptides Are Expressed through Pregnancy and Regulated by Interleukin-6 Deficiency in Mouse Placenta.

Authors:  Patricia Pazos; Luis Lima; Carlos Diéguez; María C García
Journal:  Int J Endocrinol       Date:  2014-03-12       Impact factor: 3.257

10.  Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle.

Authors:  F Anesten; C Santos; E Gidestrand; E Schéle; V Pálsdóttir; T Swedung-Wettervik; B Meister; K Patrycja Skibicka; J-O Jansson
Journal:  J Neuroendocrinol       Date:  2017-12       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.